BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 35780705)

  • 21. Improved Prostate Cancer Biopsy Grading by Incorporation of Invasive Cribriform and Intraductal Carcinoma in the 2014 Grade Groups.
    van Leenders GJLH; Kweldam CF; Hollemans E; Kümmerlin IP; Nieboer D; Verhoef EI; Remmers S; Incrocci L; Bangma CH; van der Kwast TH; Roobol MJ
    Eur Urol; 2020 Feb; 77(2):191-198. PubMed ID: 31439369
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gleason grading of prostate cancer in needle core biopsies: a comparison of general and urologic pathologists.
    Al-Maghrabi JA; Bakshi NA; Farsi HM
    Ann Saudi Med; 2013; 33(1):40-4. PubMed ID: 23458939
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PIN-like (Ductal) Adenocarcinoma of the Prostate.
    Paulk A; Giannico G; Epstein JI
    Am J Surg Pathol; 2018 Dec; 42(12):1693-1700. PubMed ID: 30138215
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Limited Adenocarcinoma of the Prostate on Needle Core Biopsy.
    Bell PD; Teramoto Y; Gurung PMS; Yang Z; Miyamoto H
    Arch Pathol Lab Med; 2022 Apr; 146(4):469-477. PubMed ID: 35020802
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Grade migration and important prognostic factors in a pathology specimen for radical radiotherapy in prostate cancer patients.
    Majewski W; Lange D; Stanek-Widera A; Itrych B; Krzysztofiak T; Jarząb M; Oczko-Wojciechowska M; Kajor M; Tarnawski R
    Pol J Pathol; 2022; 73(1):27-33. PubMed ID: 35848478
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gleason score 3 + 4=7 prostate cancer with minimal quantity of gleason pattern 4 on needle biopsy is associated with low-risk tumor in radical prostatectomy specimen.
    Huang CC; Kong MX; Zhou M; Rosenkrantz AB; Taneja SS; Melamed J; Deng FM
    Am J Surg Pathol; 2014 Aug; 38(8):1096-101. PubMed ID: 24832163
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of prostate biopsy secondary pathology review on radiotherapy management.
    Siedow M; Eisner M; Yaney A; Washington I; Zynger D; Martin D; Mo X; Diconstanzo D; Diaz DA
    Prostate; 2022 Feb; 82(2):210-215. PubMed ID: 34698410
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gleason scores of prostate biopsy and radical prostatectomy specimens over the past 10 years: is there evidence for systematic upgrading?
    Smith EB; Frierson HF; Mills SE; Boyd JC; Theodorescu D
    Cancer; 2002 Apr; 94(8):2282-7. PubMed ID: 12001128
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Automated deep-learning system for Gleason grading of prostate cancer using biopsies: a diagnostic study.
    Bulten W; Pinckaers H; van Boven H; Vink R; de Bel T; van Ginneken B; van der Laak J; Hulsbergen-van de Kaa C; Litjens G
    Lancet Oncol; 2020 Feb; 21(2):233-241. PubMed ID: 31926805
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The modified International Society of Urological Pathology system improves concordance between biopsy and prostatectomy tumour grade.
    Hennes DMZB; Sewell J; Kerger M; Hovens CM; Peters JS; Costello AJ; Ryan A; Corcoran NM
    BJU Int; 2021 Dec; 128 Suppl 3():45-51. PubMed ID: 34310033
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Downgrading of biopsy based Gleason score in prostatectomy specimens.
    Treurniet KM; Trudel D; Sykes J; Evans AJ; Finelli A; Van der Kwast TH
    J Clin Pathol; 2014 Apr; 67(4):313-8. PubMed ID: 24403214
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gleason grading challenges in the diagnosis of prostate adenocarcinoma: experience of a single institution.
    Chen SD; Fava JL; Amin A
    Virchows Arch; 2016 Feb; 468(2):213-8. PubMed ID: 26563400
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of adverse pathology features in grade group 2 prostatectomy specimens with syn- or metachronous metastatic disease.
    Ma C; Downes M; Jain R; Ientilucci M; Fleshner N; Perlis N; van der Kwast T
    Prostate; 2022 Feb; 82(3):345-351. PubMed ID: 34878188
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Gleason pattern 4 in radical prostatectomy specimens in current practice - Quantification, morphology and concordance with biopsy.
    de Souza MF; de Azevedo Araujo ALC; da Silva MT; Athanazio DA
    Ann Diagn Pathol; 2018 Jun; 34():13-17. PubMed ID: 29661718
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathological upgrading at radical prostatectomy for patients with Grade Group 1 prostate cancer: implications of confirmatory testing for patients considering active surveillance.
    Kaye DR; Qi J; Morgan TM; Linsell S; Ginsburg KB; Lane BR; Montie JE; Cher ML; Miller DC;
    BJU Int; 2019 May; 123(5):846-853. PubMed ID: 30248225
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Accuracy of prostate biopsies for predicting Gleason score in radical prostatectomy specimens: nationwide trends 2000-2012.
    Danneman D; Drevin L; Delahunt B; Samaratunga H; Robinson D; Bratt O; Loeb S; Stattin P; Egevad L
    BJU Int; 2017 Jan; 119(1):50-56. PubMed ID: 26918298
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Surface-enhanced Raman spectroscopy of preoperative serum samples predicts Gleason grade group upgrade in biopsy Gleason grade group 1 prostate cancer.
    Qian H; Shao X; Zhu Y; Fan L; Zhang H; Dong B; Wang Y; Xu F; Zhen W; Kang X; Chen N; Liu S; Pan J; Xue W
    Urol Oncol; 2020 Jun; 38(6):601.e1-601.e9. PubMed ID: 32241690
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of concordance of Gleason score between prostate biopsy and radical prostatectomy.
    Mansouri N; Msakni I; Gargouri F; Khiari R; Bouziani A; Laabidi B
    Tunis Med; 2018 Jul; 96(7):430-436. PubMed ID: 30430487
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contemporary Gleason Grading of Prostatic Carcinoma: An Update With Discussion on Practical Issues to Implement the 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma.
    Epstein JI; Amin MB; Reuter VE; Humphrey PA
    Am J Surg Pathol; 2017 Apr; 41(4):e1-e7. PubMed ID: 28177964
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prostate Cancer Genomic Classifier Relates More Strongly to Gleason Grade Group Than Prostate Imaging Reporting and Data System Score in Multiparametric Prostate Magnetic Resonance Imaging-ultrasound Fusion Targeted Biopsies.
    Martin DT; Ghabili K; Levi A; Humphrey PA; Sprenkle PC
    Urology; 2019 Mar; 125():64-72. PubMed ID: 30552940
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.